Cargando…
A new strategy for cardiac protection
It may be possible to treat cardiac hypertrophy and injury by using drugs that inhibit a protein called SIRT2.
Autores principales: | Bouhamida, Esmaa, Chaudhry, Hina W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10622142/ https://www.ncbi.nlm.nih.gov/pubmed/37917118 http://dx.doi.org/10.7554/eLife.93239 |
Ejemplares similares
-
Perspectives on mitochondrial relevance in cardiac ischemia/reperfusion injury
por: Pedriali, Gaia, et al.
Publicado: (2022) -
Mitochondrial Oxidative Stress and “Mito-Inflammation”: Actors in the Diseases
por: Patergnani, Simone, et al.
Publicado: (2021) -
Some Insights into the Regulation of Cardiac Physiology and Pathology by the Hippo Pathway
por: Ramaccini, Daniela, et al.
Publicado: (2022) -
Relevance of Autophagy and Mitophagy Dynamics and Markers in Neurodegenerative Diseases
por: Giorgi, Carlotta, et al.
Publicado: (2021) -
Mitochondrial Bioenergetics and Dynamism in the Failing Heart
por: Morciano, Giampaolo, et al.
Publicado: (2021)